GF Fund Management
AGIO icon

GF Fund Management’s Agios Pharmaceuticals AGIO Stock Holding History

GF Fund Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$50.4K Buy
1,517
+275
+22% +$9.6K ﹤0.01% 390
2026
Q2 		$46.1K Sell
1,242
-68
-5% -$2.06K ﹤0.01% 396
2026
Q1 		$44.3K Buy
1,310
+165
+14% +$4.68K ﹤0.01% 415
2025
Q4 		$31.2K Sell
1,145
-105
-8% -$3.68K ﹤0.01% 454
2025
Q3 		$50.2K Sell
1,250
-210
-14% -$7.9K ﹤0.01% 393
2025
Q2 		$48.6K Hold
1,460
– – ﹤0.01% 417
2025
Q1 		$42.8K Buy
1,460
+263
+22% +$8.72K ﹤0.01% 436
2024
Q4 		$39.3K Buy
+1,197
New +$56.2K ﹤0.01% 416

Other funds holding AGIO

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

GF Fund Management's AGIO Position: Q3 2026 in Review

GF Fund Management increased its Agios Pharmaceuticals (AGIO) stake by 22% in Q3 2026, buying an estimated $9.6K and bringing the position to 1,517 shares worth $50.4K. The position accounts for ﹤0.01% of the portfolio, ranked #390.

GF Fund Management first reported a position in AGIO in Q4 2024 and has held it in 8 quarters since. 43 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • GF Fund Management held 1,517 shares of Agios Pharmaceuticals worth $50.4K as of Q3 2026.
  • GF Fund Management bought 275 Agios Pharmaceuticals shares in Q3 2026, an estimated $9.6K.
  • Agios Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #390 holding.
  • GF Fund Management first reported a position in Agios Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • 43 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.